Panagora Asset Management’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-136,133
| Closed | -$6.31M | – | 2792 |
|
|
2019
Q2 | $6.31M | Sell |
136,133
-1,020,223
| -88% | -$28.6M | 0.03% | 440 |
|
|
2019
Q1 | $28.2M | Buy |
1,156,356
+258,401
| +29% | +$5.38M | 0.13% | 172 |
|
|
2018
Q4 | $12.8M | Sell |
897,955
-255,067
| -22% | -$3.87M | 0.06% | 265 |
|
|
2018
Q3 | $17.5M | Sell |
1,153,022
-6,098
| -0.5% | -$93.4K | 0.07% | 254 |
|
|
2018
Q2 | $19.4M | Sell |
1,159,120
-21,671
| -2% | -$345K | 0.08% | 236 |
|
|
2018
Q1 | $19.3M | Buy |
1,180,791
+4,346
| +0.4% | +$69.6K | 0.08% | 232 |
|
|
2017
Q4 | $15.1M | Sell |
1,176,445
-48,939
| -4% | -$557K | 0.06% | 303 |
|
|
2017
Q3 | $15.1M | Sell |
1,225,384
-7,127
| -0.6% | -$66.2K | 0.06% | 308 |
|
|
2017
Q2 | $10.3M | Sell |
1,232,511
-40,119
| -3% | -$328K | 0.04% | 399 |
|
|
2017
Q1 | $11.4M | Buy |
1,272,630
+13,001
| +1% | +$138K | 0.05% | 384 |
|
|
2016
Q4 | $11.1M | Sell |
1,259,629
-133,667
| -10% | -$984K | 0.05% | 347 |
|
|
2016
Q3 | $9.4M | Sell |
1,393,296
-197,107
| -12% | -$762K | 0.04% | 374 |
|
|
2016
Q2 | $5.66M | Sell |
1,590,403
-86,351
| -5% | -$281K | 0.03% | 508 |
|
|
2016
Q1 | $4.95M | Buy |
1,676,754
+895,303
| +115% | +$2.68M | 0.02% | 577 |
|
|
2015
Q4 | $3.3M | Buy |
781,451
+50,380
| +7% | +$230K | 0.02% | 658 |
|
|
2015
Q3 | $3.33M | Sell |
731,071
-10,452
| -1% | -$62K | 0.02% | 608 |
|
|
2015
Q2 | $5.35M | Buy |
741,523
+118,512
| +19% | +$875K | 0.03% | 512 |
|
|
2015
Q1 | $4.59M | Buy |
623,011
+1,144
| +0.2% | +$8.14K | 0.02% | 525 |
|
|
2014
Q4 | $2.94M | Buy |
621,867
+31,739
| +5% | +$126K | 0.02% | 613 |
|
|
2014
Q3 | $2.11M | Sell |
590,128
-32,391
| -5% | -$128K | 0.01% | 731 |
|
|
2014
Q2 | $2.84M | Buy |
622,519
+339,355
| +120% | +$1.4M | 0.01% | 700 |
|
|
2014
Q1 | $1.33M | Sell |
283,164
-2,561
| -0.9% | -$12.9K | 0.01% | 1050 |
|
|
2013
Q4 | $1.43M | Sell |
285,725
-11,864
| -4% | -$64.6K | 0.01% | 1015 |
|
|
2013
Q3 | $1.85M | Sell |
297,589
-48,541
| -14% | -$288K | 0.01% | 841 |
|
|
2013
Q2 | $1.57M | Buy |
+346,130
| New | +$1.86M | 0.01% | 876 |
|
Other funds holding ARRY
Panagora Asset Management's ARRY Position: Q3 2019 in Review
Panagora Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 136,133 shares — an estimated $6.31M sold.
Panagora Asset Management first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $28.2M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Panagora Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Panagora Asset Management sold 136,133 Array Biopharma Inc shares in Q3 2019, an estimated $6.31M.
- Panagora Asset Management first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
- Panagora Asset Management's Array Biopharma Inc position peaked at $28.2M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.